Levita Magnetics International Corp.

Levita Magnetics International Corp. is a U. S. -based company specializing in advanced surgical technologies, specifically the MARS (Magnetic Assisted Robotic Surgery) platform, designed to enhance minimally invasive surgical procedures.

Founded in 2011 and headquartered in Menlo Park, US, Levita Magnetics develops innovative surgical solutions focusing on reducing invasiveness in surgery. The company has successfully completed 9 deals, with the latest funding round being a Series C raised on March 1, 2024, amounting to USD 20. 11 mn, led by Ballast Capital. The founder and CEO, Alberto Rodriguez-Navarro, has a history in developing medical technologies, further positioning the company as a key player in surgical advancements.

Levita Magnetics specializes in a revolutionary surgical platform known as MARS (Magnetic Assisted Robotic Surgery), which utilizes advanced magnetic technology to facilitate minimally invasive surgical procedures. The MARS system is designed to enhance surgical precision while reducing patient recovery times and overall healthcare costs. This innovative product seeks to address the limitations of traditional surgical methods by significantly decreasing the invasiveness of procedures, thereby improving patient outcomes and safety. The primary clientele includes hospitals and surgical centers, with end users being patients who require surgical intervention for various medical conditions, particularly in fields such as general surgery and specialized surgical practices.

Levita Magnetics primarily markets its products to healthcare institutions in North America, Europe, and select regions in Asia, catering to a growing demand for advanced surgical technologies in these markets. Levita Magnetics generates revenue through the direct sale of its MARS surgical systems to hospitals and surgical facilities, capitalizing on a B2B transaction model. The company structures its sales through partnerships with healthcare providers, enabling these institutions to integrate the MARS system into their operational frameworks. Revenue streams are derived from the initial equipment purchase, complemented by ongoing support and maintenance services.

The flagship MARS system, along with any associated accessories or consumables, constitutes a significant part of the company's offerings, providing both upfront and recurring revenue opportunities. The pricing structure for these services is tailored to the needs of healthcare providers, reflecting the value added by the advanced surgical capabilities offered by Levita Magnetics. Levita Magnetics aims to enhance its product offerings and market reach. The funding acquired in March 2024 will be instrumental in advancing the development of new products within the MARS platform and exploring additional features that improve surgical efficiency.

The company is also targeting market expansion into Asia and Europe, with a focus on integrating their systems into new healthcare facilities by 2025. The recent acquisition of an undisclosed stake by Vizcaya Capital will support these ambitions, allowing Levita Magnetics to scale its operations and further innovate in the surgical technology sector.